After Clinical Setbacks, Theravance Axes 75% of Workforce and Refocuses on Respiratory Drugs

September 16, 2021

Category: News

Intent on bouncing back from a pair of later-phase clinical trial failures, Theravance Biopharma said it will eliminate about 75% of its workforce—270 jobs—and slash its R&D budget next year through a restructuring that will refocus the company on respiratory […]

Why Aren’t COVID Vaccines Getting to People Globally?

September 8, 2021

Category: Industry, Vaccines

The highly transmissible Delta variant of COVID-19 has highlighted a fear shared by infectious disease experts worldwide: That increasingly dangerous mutations will continue to crop up until most people around the globe are vaccinated. “There are going to be more […]

After criticism, Johnson & Johnson COVID-19 vaccines shipped from South Africa to Europe to be returned

September 2, 2021

Category: News

Johnson & Johnson drew sharp criticism two weeks ago amid reports that doses of its single-shot COVID-19 vaccine produced in South Africa were being exported to Europe. Now, it appears that the arrangement is coming to an end. J&J doses […]

Industry, Vaccines

Moderna Highlights New Clinical Data on its COVID-19 Vaccine

September 15, 2021


Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today highlighted a new analysis suggesting that the Moderna COVID-19 vaccine is highly effective against circulating variants of concern, including in a vaccine effectiveness study conducted […]

FDA, Pricing, Regulations

To lower drug prices, Senate leaders, FDA urge U.S. Patent and Trademark Office to alter patent processes

September 14, 2021

Via: FiercePharma

The Senate and the FDA are appealing to the U.S. Patent and Trademark Office (USPTO) to examine how it can limit the ability of pharmaceutical companies to leverage patent strategies to extend their drug monopolies. In separate letters last week […]

FDA, Regulations

FDA starts pilot after AstraZeneca, J&J make case for novel drug delivery excipients

September 14, 2021

Via: FiercePharma

Academic literature features a steady stream of papers on novel excipients with the potential to improve drug delivery but they rarely show up in newly approved drugs because companies shy away from the additional risk they entail. Recognizing that, the […]

Manufacturing, Research and Development

AGC Biologics Expands pDNA and mRNA Manufacturing Capacity

September 14, 2021

Via: Contract Pharma

AGC Biologics, a global biopharmaceutical contract development and manufacturing organization (CDMO), unveiled expansion plans for the company’s Heidelberg facility to increase manufacturing capacities for plasmid-DNA (pDNA) and messenger RNA (mRNA) projects. With this expansion, AGC Biologics is boosting its current […]

Cell and Gene Therapy, Industry

AbbVie bets big on a gene therapy for eye diseases

September 13, 2021

Via: Biopharma Dive

While estimates vary, AMD is thought to affect a large number of people. A study published in 2014, for instance, projected the patient population globally would hit 196 million in 2020 and grow to 288 million by 2040. Among those […]